The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice

Neurosci Lett. 2012 Feb 16;509(2):69-71. doi: 10.1016/j.neulet.2011.12.029. Epub 2011 Dec 27.

Abstract

The glutamate transporter GLT-1 is primarily responsible for glutamate clearance in the spinal cord. beta-Lactam antibiotics have been shown to attenuate neuropathic pain behaviors by promoting GLT-1 expression and function in the CNS. The present study tested the hypothesis that ceftriaxone, a prototype beta-lactam antibiotic, can prevent the development of opioid-induced hyperalgesia (OIH) in mice. Repeated morphine administration produced mechanical allodynia and thermal hyperalgesia, signs of OIH, and reduced spinal GLT-1 expression in mice. Ceftriaxone (200mg/kg/d, i.p., for 7 d) inhibited OIH. Correlating with the behavioral effects, ceftriaxone reversed downregulation of GLT-1 expression that was induced by OIH. These results suggest that ceftriaxone inhibited the development of OIH by up-regulating spinal GLT-1 expression.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / pharmacology*
  • Down-Regulation / drug effects
  • Excitatory Amino Acid Transporter 2 / biosynthesis
  • Excitatory Amino Acid Transporter 2 / metabolism
  • Hyperalgesia / chemically induced*
  • Hyperalgesia / prevention & control*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Morphine / administration & dosage
  • Morphine / pharmacology
  • Spinal Cord / drug effects
  • Spinal Cord / enzymology
  • Up-Regulation / drug effects
  • beta-Lactams / pharmacology*

Substances

  • Analgesics, Opioid
  • Anti-Bacterial Agents
  • Excitatory Amino Acid Transporter 2
  • beta-Lactams
  • Ceftriaxone
  • Morphine